Monday - Friday:
9:00am - 5:00pm (EST)
We have reached the mandatory goal of 100,000 signatures! Now let's show the White House we mean business and collect even more! It is not too late to sign!
SCDAA along with its members, advocates and champions has secured a big win for the sickle cell community. On Wednesday, July 16, 2014 Representatives Danny K. Davis (D-IL) and Michael C. Burgess (R-TX) revealed bipartisan legislation...
Bluebird Bio announced that the first subject with severe sickle cell disease has undergone infusion with LentiGlobin BB305 drug product in an autologous hematopoietic stem cell transplantation.
Baxter International Inc. announced the acquisition of AesRx, LLC, including the development and commercialization of Aes-103, an investigational prophylactic treatment for sickle cell disease (SCD).
SCDAA would like to thank you for being an advocate for sickle cell disease!
Continue to check our website for updates.